We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

286 hedge funds and large institutions have $2.79B invested in Amedisys in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 115 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more funds holding in top 10

Funds holding in top 10: 2 → 11 (+9)

2% more capital invested

Capital invested by funds: $2.74B → $2.79B (+$55.1M)

1.32% less ownership

Funds ownership: 91.96% → 90.64% (-1.3%)

5% less funds holding

Funds holding: 301 → 286 (-15)

22% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 115

26% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 53

93% less call options, than puts

Call options by funds: $5.97M | Put options by funds: $81.6M

Holders
286
Holders Change
-15
Holders Change %
-4.98%
% of All Funds
4.54%
Holding in Top 10
11
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+450%
% of All Funds
0.17%
New
39
Increased
90
Reduced
115
Closed
53
Calls
$5.97M
Puts
$81.6M
Net Calls
-$75.6M
Net Calls Change
-$69.6M

Top Buyers

1
PCM
Pentwater Capital Management
Florida
+$74.6M
2
PWAM
Park West Asset Management
California
+$60.8M
3
WCMNY
Westchester Capital Management (New York)
New York
+$57.3M
4
Millennium Management
Millennium Management
New York
+$55.9M
5
FCM
Farallon Capital Management
California
+$39.2M

Top Sellers

1
DM
Deerfield Management
New York
-$164M
2
RP
Riverbridge Partners
Minnesota
-$144M
3
JP Morgan Chase
JP Morgan Chase
New York
-$93.6M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$55.7M
5
Ameriprise
Ameriprise
Minnesota
-$38.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFB
326
Cullen/Frost Bankers
Texas
– -$28.3K -309 Closed
LSA
327
Leonteq Securities AG
Switzerland
– -$27.4K -300 Closed
PI
328
PineBridge Investments
New York
– -$26.2K -287 Closed
TFP
329
Tilia Fiduciary Partners
North Carolina
– -$18.7K -204 Closed
RI
330
Ridgewood Investments
New Jersey
– -$15.9K -174 Closed
CFGS
331
Concourse Financial Group Securities
Alabama
– -$15.2K -165 Closed
QT
332
Quantbot Technologies
New York
– -$14.8K -162 Closed
CT
333
Colonial Trust
South Carolina
– -$11.2K -122 Closed
TPCW
334
TD Private Client Wealth
New York
– -$3.29K -36 Closed
CAM
335
ClariVest Asset Management
California
– -$1K -12 Closed
UB
336
UMB Bank
Missouri
– -$914 -10 Closed
BTI
337
Blue Trust Inc
Georgia
– -$1K -9 Closed
2L
338
25 LLC
Missouri
– -$634 -7 Closed
DI
339
Disciplined Investments
Oklahoma
– -$457 -5 Closed
10 11 12 13
14

AMED Hedge Fund Activity: Q3 2023 in Review

286 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2023, worth a combined $2.79B — up 2% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of AMED and 39 opened new positions — a net loss of 14 holders — while 115 trimmed existing stakes and 90 added.

The largest buyer was Pentwater Capital Management, adding an estimated $74.6M. The largest seller was Deerfield Management, exiting entirely with an estimated $164M sold.

  • 286 institutional investors held Amedisys (AMED) as of Q3 2023, down from 301 in Q2 2023.
  • Funds reported $2.79B of Amedisys stock for Q3 2023, up 2% quarter-over-quarter.
  • 39 funds opened new Amedisys positions in Q3 2023 and 53 closed out, a net change of -14 holders.
  • The largest Amedisys buyer in Q3 2023 was Pentwater Capital Management, an estimated $74.6M added.
  • The largest Amedisys seller in Q3 2023 was Deerfield Management, an estimated $164M sold.

Based on aggregated 13F filings for Q3 2023.